AlphAIAlphAI — Financial news for AI agents
tradingview.com$YHGJ

Yunhong Green CTI 3Q 2026: Revenue $3.13M, EPS ($0.35) — 10-Q Summary

Yunhong Green CTI reported 3Q 2026 revenue of $3.13M, up 6% YoY, with a net loss of $909K, 6% wider than last year. Foil balloon sales rose 7%, while film product sales dropped 73%. The company cited improved product mix for lower costs but expressed doubt about its ability to continue operations without additional financing.

Original reporting
tradingview.com
Published Nov 13, 2026, 3:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 3:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Yunhong Green CTI 3Q 2026: Revenue $3.13M, EPS ($0.35) — 10-Q Summary — source image
Source · tradingview.com
Decision brief

The 30-second read

$YHGJBearishMed
01

Why it matters

The earnings miss and going‑concern notice are fresh disclosures that could trigger immediate price adjustments.

02

Market read

First‑report earnings for a micro‑cap with a widened loss and liquidity concerns; likely to cause short‑term downside pressure.

03

What to watch

Potential upside from the 7% growth in foil‑balloon sales and higher‑margin product mix.

Relevance 6/10Novelty 8/10Timing: today

Background

The article is an AI‑generated summary of Yunhong Green CTI's 10‑Q filing, presenting the latest quarterly financials and liquidity warning.

Company-level read

Ticker impact

$YHGJBearishHigh confidence
Context

Yunhong Green CTI reported Q3 2026 revenue of $3.13M and a net loss of $909K, widening loss and going‑concern doubts.

Expected impact

downward pressure as investors price in the widened loss and going‑concern warning

Evidence & confidence

The company posted a larger loss than a year ago and disclosed substantial doubt about its ability to continue as a going concern, which typically triggers sell‑offs in micro‑cap stocks.

Market effects

Sector

Highlights weakness in the niche balloon and film product segment, may affect peers in specialty packaging.

Regional

Limited to investors tracking micro‑caps and niche consumer‑goods stocks.

Global

Low; the filing is company‑specific with minimal broader market impact.

Counterpoint

What could challenge this read

If the company can secure new financing, the stock could rebound on a short‑cover rally.

Key entities

  • company
    Yunhong Green CTI Ltd.

    Specialty balloon and film product manufacturer reporting Q3 2026 results.

Read at source← All news

Related articles

$SBCHigh

Why SBC Medical Stock Skyrocketed on Friday

SBC Medical Group (NASDAQ:SBC) shares rose 37% after reporting Q3 revenue of $59M, up 35% YoY, and announcing an AI partnership with NeuroBrain Dynamics. The company added 36 clinics, increasing total locations to 293, and saw a 9% rise in patient visits. Operating income surged 66% to $26M, with a 45% operating margin.

finance.yahoo.com
$BTOMedAI 8/10

B2Gold Earnings Call Signals Lower Costs and Growth

B2Gold Corp. reported Q3 earnings with strong production, lower cost guidance, and positive free cash flow. The company produced 193,000 ounces of gold, reduced all-in sustaining cost guidance by over $100 per ounce, and generated $48 million in free cash flow. Revenue reached $836 million, supported by higher gold prices. The company also highlighted growth projects and shareholder returns.

tipranks.com
$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

finance.yahoo.com
$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

finance.yahoo.com
$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

finance.yahoo.com
$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.

finance.yahoo.com